Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Ekso Bionics Stock Prices Surge Following Q4 Financial Results

Elaine Mendonca by Elaine Mendonca
March 4, 2024
in Breaking News
0
Biotechnology Markets and money
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter

Ekso Bionics is seeing a surge in their stock prices following the release of their Q4 financial results, which were a mixed bag. The company is set to unveil their full financial and business results for the fourth quarter and the entire year of 2023 on March 4, 2024. Analysts are predicting a significant 54.2% increase in EPS and a 34.4% rise in earnings for the company.

Specializing in exoskeleton solutions, Ekso Bionics is renowned for their products that boost strength, endurance, and mobility in both medical and industrial fields. Their innovative wearable robots cater to individuals of all abilities, providing assistance for a wide range of needs from rehabilitation to improving human performance in the workplace.

EKSO Stock Shows Strong Price Momentum on March 4, 2024 – Investors Advised to Monitor Performance

On March 4, 2024, EKSO stock showed positive price momentum as it traded in the middle of its 52-week range and above its 200-day simple moving average. The stock closed at $2.10, showing a price increase of $0.11 or 5.53% since the market last closed. Despite the positive performance during regular trading hours, EKSO stock experienced a slight drop of $0.04 in after-hours trading. Overall, EKSO stock displayed strong price momentum on March 4, 2024. Investors should continue to monitor the stock’s performance and any potential news or developments that could impact its price in the future.

Ekso Bionics Holdings, Inc. (EKSO) Financial Performance Update March 4, 2024

On March 4, 2024, Ekso Bionics Holdings, Inc. (EKSO) saw mixed performance in its financial metrics. According to data from CNN Money, the company reported total revenue of $12.91 million for the past year, which represented a 14.81% increase compared to the previous year. However, total revenue for the most recent quarter was $4.61 million, which remained flat compared to the previous quarter. In terms of net income, Ekso reported a net loss of $15.08 million for the past year, marking a 54.44% decrease from the previous year. However, the net loss for the most recent quarter improved to $3.37 million, representing a 20.45% increase compared to the previous quarter. Earnings per share (EPS) for Ekso showed a similar trend. The company reported an EPS of -$1.16 for the past year, reflecting a 32.25% decrease from the previous year. However, EPS for the most recent quarter improved to -$0.24, showing a 22.92% increase compared to the previous quarter. Overall, Ekso’s financial performance on March 4, 2024, showed a mixed bag of results. While the company saw improvements in net income and EPS on a quarterly basis, there were declines in these metrics on a yearly basis. The flat total revenue for the most recent quarter may indicate stability in the company’s revenue stream. Investors will likely keep a close eye on Ekso’s future financial reports to see if the company can sustain or improve upon its recent performance.

Tags: EKSO
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Albemarle Corporation Announces 175 Billion Depositary Shares Offering with JP Morgan and BofA Securities as Joint BookRunning Managers

Finance_Commercial

Century Communities Inc Announces CFO Transition and Search for Successor

Title Select Water Solutions Announces Executive Reshuffle with Appointment of New CFO

Recommended

Amazon Stock

Amazon Faces Regulatory Setback While Pushing AI and Retail Expansion

6 months ago
Energy Vault Holdings Stock

Energy Vault’s Strategic Pivot Gains Momentum with Major Texas Acquisition

5 months ago
COREWEAVE INC-CL A Stock

CoreWeave Shares Face Critical Earnings Test

5 months ago
Uranium Energy Stock

Uranium Energy Stock: A Market Paradox

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Ocugen Shares Slide Despite Positive Clinical Trial Results

Regulatory Rebuke Sends ImmunityBio Shares Tumbling

Realty Income’s Strategic Financing Defies High Interest Rate Environment

IBM Shares Face Pressure from Analyst Downgrades and Acquisition Concerns

Battalion Oil Navigates Debt and Operational Overhaul

Divergent Analyst Views Highlight Coeur Mining’s Strategic Transition

Trending

Energiekontor Stock
Energy & Oil

Energiekontor Stock Gains Momentum from Policy Shifts

by Rodolfo Hanigan
March 25, 2026
0

While Energiekontor's share price has faced significant headwinds this year, declining roughly 12% since January and over...

Bionxt Solutions Stock

BioNxt Solutions Enters Pivotal Commercial Phase with Key Patents

March 25, 2026
Take-Two Stock

GTA VI Launch Date Sets Stage for Take-Two’s Financial Horizon

March 25, 2026
Ocugen Stock

Ocugen Shares Slide Despite Positive Clinical Trial Results

March 25, 2026
ImmunityBio Stock

Regulatory Rebuke Sends ImmunityBio Shares Tumbling

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Energiekontor Stock Gains Momentum from Policy Shifts
  • BioNxt Solutions Enters Pivotal Commercial Phase with Key Patents
  • GTA VI Launch Date Sets Stage for Take-Two’s Financial Horizon

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com